H.R. 2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act
Before you vote › Federal bills
H.R. 2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act
117th Congress · introduced 2021-04-28 · Commerce · Latest: Ordered to be Reported in the Nature of a Substitute by Voice Vote.
federal
Follow this bill, step by step
- Where it came from: introduced 2021-04-28 · official record
- Who proposed it: Rep. Johnson, Henry C. "Hank," Jr. [D-GA-4] · what a sponsor is
- What happened next: no floor votes in our records yet. Why?
- Where it stands now: Ordered to be Reported in the Nature of a Substitute by Voice Vote. Not final yet: this can still change. We check for updates every day.
- If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.
Official title
Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act
Plain summary
Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act This bill limits in certain instances the number of patents that the manufacturer of a biologic drug can assert in a lawsuit against a company seeking to sell a biosimilar version of that drug. (A biologic drug is produced through natural processes or isolated from natural sources. A biosimilar version is substantially similar to the original biologic, which is the reference product, and is often marketed as a less expensive alternative.) The bill's provisions apply to an existing framework that gives the biosimilar manufacturer an abbreviated path to Food and Drug Administration approval to sell the biosimilar. Specifically, if the biosimilar manufacturer completes certain actions under the framework, such as sharing certain information about its product with the reference product manufacturer, the bill limits the number of certain patents that the reference product manufacturer may assert in a lawsuit, such as patents that were filed more than four years after the reference product received market approval. The limit shall not apply to patents claiming certain methods for using the biologic drug. The court in which the infringement lawsuit is filed may increase the limit if justice so requires or if there is good cause for the increase.
Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.
What a vote does
A “Yea” vote
If it passes both chambers and is signed, it becomes law.
A “Nay” vote
If it is not passed, current law stays as it is.
PSI Sci description of the legislative step (not an opinion).
What does this mean? (plain words)
Official text
Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act
Source: Congressional Research Service summary (Introduced in House)
AI explanation – may be wrong, check the official text
No AI explanation yet. It takes up to a minute to write and is then saved for everyone.
Limited to a few requests an hour per person.
The strongest published arguments
Arguments for (supporters)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Arguments against (opponents)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Alternatives
Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.
How did my representative vote? · This bill's floor votes
Officials and money
Sponsor: Rep. Johnson, Henry C. "Hank," Jr. [D-GA-4] · 2 cosponsors
Cosponsors on this site
Darrell Issa (R-CA)
Sponsor's campaign money: Rep. Johnson, Henry C. "Hank," Jr. [D-GA-4] reported raising $514,399 (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.
No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.
Words on this page, explained (1)
- Bill
- A proposed law. It becomes law only if it passes the legislature and is signed by the president or governor (or a veto is overridden).
Plain meanings written from linked sources. All words.
Sources
- Congressional Research Service summary (Introduced in House)
- Congress.gov
- Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-117hr2884.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr>
Record fed-us-cong117-hr2884 · catalog fed-us-congress-bills-cong117 · updated 2026-11-15 by psicol fed-bills-cong117